FDA Inspection 1156014 — RLC Labs Inc.

RLC Labs Inc. — FEI 3002523846

The FDA completed an inspection of RLC Labs Inc. on November 4, 2021 in Phoenix, AZ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 4, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Phoenix, AZ (United States)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
430521 CFR 211.68(b)Backup data not assured as exact and complete